Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Melanoma is added as a topic, and MedlinePlus Genetics is listed as a related resource. The page revision was updated from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T18:11:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The related topics section was trimmed by removing Melanoma and MedlinePlus Genetics entries. This reduces the external resources shown alongside the study details.
    Difference
    0.2%
    Check dated 2026-07-11T13:09:54.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page. This update does not alter the study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-04T08:30:52.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Melanoma as a topic and related topics (MedlinePlus Genetics) were added. The page revision updates the version from v3.6.0 to v3.6.2.
    Difference
    0.2%
    Check dated 2026-06-27T06:30:57.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Removed the Melanoma tag, the related topics header, and the MedlinePlus Genetics link from the page's related topics area. This changes the page's metadata and related-resource references without altering the main study content.
    Difference
    0.2%
    Check dated 2026-06-20T05:00:58.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    The page gained new navigation and help sections (including a recruitment notice and How to Read a Study Record, Common Questions, How to Join a Study) and related topic tags, with a Revision note updated to v3.6.0. The 'Intervention / Treatment' heading was removed.
    Difference
    0.6%
    Check dated 2026-06-13T00:22:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.